Clinical Trials for Berlin-Chemie

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Berlin-Chemie

Clinical Trials (5)

NCT07156916
A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions
PHASE1Recruiting
46 participants
Started: Sep 8, 2025 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT07201584
A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:
PHASE1Recruiting
26 participants
Started: Sep 5, 2025 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT07091669
A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin 0.4 mg Tablets, in Healthy Adult Male Subjects, Under Fed Conditions
PHASE1Active, not recruiting
46 participants
Started: Jun 16, 2025 · Completed: Nov 22, 2025
2 conditions1 sponsor1 location
NCT07146711
A Comparative Bioavalability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tabsulosine 0.4 mg Tablets in Healthy Adult Male Subjects, at Steady State
PHASE1Active, not recruiting
33 participants
Started: Mar 3, 2025 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05963997
A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer
PHASE1/PHASE2Active, not recruiting
49 participants
Started: Oct 9, 2023 · Completed: Dec 23, 2025
3 conditions2 sponsors23 locations